Senior Associate Scientist, Analytical Sciences at Bristol-Myers Squibb

Seattle, Washington, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

3-5 years of hands-on experience with flow cytometry method execution, analysis, instrumentation, maintenance, software, and troubleshooting
Demonstrated hands-on experience with key analytical technologies and platforms (e.g., BD flow cytometry instruments, Luminex, Incucyte, FlowJo, Benchling, and other relevant tools); experience with several preferred
Ability to quickly adapt to new technologies as needed for cell therapy analytics
Excellent aseptic technique and experience with mammalian and/or primary cell culture
Demonstrated ability to communicate and justify technical decisions and actions to cross-functional stakeholders
Experience and ability to represent a team in cross-functional settings
Independently motivated with ability to multi-task, problem-solve, and coordinate activities within a team
Detail oriented with excellent verbal and written communication skills
Demonstrated ability to thrive on a team in a fast-paced environment, and prioritize work across multiple projects
Strong understanding of flow cytometry and cell biology

Responsibilities

Perform routine and advanced analysis of cell products for quality attributes using flow cytometry (BD instruments), cell-based assays (Luminex, Incucyte), and molecular methods
Provide technical expertise in troubleshooting analytical platforms and interpreting complex data sets
Serve as an internal technical resource, supporting team members with technical guidance
Design, plan, execute, and analyze lab experiments
Understand longitudinal data, critically assess assay performance over time, and identify trends or anomalies
Summarize and present scientific data to stakeholders
Manage inventory of samples and materials and ensure proper handling and storage
Maintain proper documentation of experimental results using an electronic lab notebook
Maintain a safe work environment in accordance with policies/procedures/regulations

Skills

flow cytometry

BD instruments

cell-based assays

Luminex

Incucyte

molecular methods

cell biology

CAR-T

gene editing

analytical development

troubleshooting

data analysis

lab experiments

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free